209 related articles for article (PubMed ID: 20353086)
1. [Ataxia-telangiectasia mutated gene and breast cancer susceptibility].
Zhang N; Che J; Bai S; Wu Z; Cui Y; Zou W
Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):9-15. PubMed ID: 20353086
[TBL] [Abstract][Full Text] [Related]
2. ATM and breast cancer susceptibility.
Ahmed M; Rahman N
Oncogene; 2006 Sep; 25(43):5906-11. PubMed ID: 16998505
[TBL] [Abstract][Full Text] [Related]
3. Contribution of mutations in ATM to breast cancer development in the Czech population.
Soukupova J; Dundr P; Kleibl Z; Pohlreich P
Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
[TBL] [Abstract][Full Text] [Related]
4. The Ataxia-telangiectasia mutated gene and breast cancer: gene expression profiles and sequence variants.
Hall J
Cancer Lett; 2005 Sep; 227(2):105-14. PubMed ID: 16112413
[TBL] [Abstract][Full Text] [Related]
5. Association between ataxia telangiectasia mutated gene polymorphisms and breast cancer in Taiwanese females.
Wang HC; Chang WS; Tsai RY; Tsai CW; Liu LC; Su CH; Cheng HN; Tsou YA; Sun SS; Lin CC; Bau DT
Anticancer Res; 2010 Dec; 30(12):5217-21. PubMed ID: 21187516
[TBL] [Abstract][Full Text] [Related]
6. Atm-haploinsufficiency enhances susceptibility to carcinogen-induced mammary tumors.
Lu S; Shen K; Wang Y; Santner SJ; Chen J; Brooks SC; Wang YA
Carcinogenesis; 2006 Apr; 27(4):848-55. PubMed ID: 16400190
[TBL] [Abstract][Full Text] [Related]
7. Association between polymorphisms of the ataxia telangiectasia mutated gene and breast cancer risk: evidence from the current studies.
Lu PH; Wei MX; Si SP; Liu X; Shen W; Tao GQ; Chen MB
Breast Cancer Res Treat; 2011 Feb; 126(1):141-8. PubMed ID: 20665102
[TBL] [Abstract][Full Text] [Related]
8. Two ATM variants and breast cancer risk.
Thompson D; Antoniou AC; Jenkins M; Marsh A; Chen X; Wayne T; Tesoriero A; Milne R; Spurdle A; Thorstenson Y; Southey M; Giles GG; Khanna KK; Sambrook J; Oefner P; Goldgar D; Hopper JL; Easton D; Chenevix-Trench G;
Hum Mutat; 2005 Jun; 25(6):594-5. PubMed ID: 15880680
[TBL] [Abstract][Full Text] [Related]
9. The ATM gene and ataxia telangiectasia.
Mavrou A; Tsangaris GT; Roma E; Kolialexi A
Anticancer Res; 2008; 28(1B):401-5. PubMed ID: 18383876
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer.
Pylkäs K; Tommiska J; Syrjäkoski K; Kere J; Gatei M; Waddell N; Allinen M; Karppinen SM; Rapakko K; Kääriäinen H; Aittomäki K; Blomqvist C; Mustonen A; Holli K; Khanna KK; Kallioniemi OP; Nevanlinna H; Winqvist R
Carcinogenesis; 2007 May; 28(5):1040-5. PubMed ID: 17166884
[TBL] [Abstract][Full Text] [Related]
11. ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations.
Brunet J; Gutiérrez-Enríquez S; Torres A; Bérez V; Sanjosé S; Galceran J; Izquierdo A; Menéndez JA; Gumà J; Borràs J
Clin Genet; 2008 May; 73(5):465-73. PubMed ID: 18384426
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk.
Lee KM; Choi JY; Park SK; Chung HW; Ahn B; Yoo KY; Han W; Noh DY; Ahn SH; Kim H; Wei Q; Kang D
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):821-5. PubMed ID: 15824150
[TBL] [Abstract][Full Text] [Related]
13. Expression patterns of the ATM gene in mammary tissues and their associations with breast cancer survival.
Ye C; Cai Q; Dai Q; Shu XO; Shin A; Gao YT; Zheng W
Cancer; 2007 May; 109(9):1729-35. PubMed ID: 17366603
[TBL] [Abstract][Full Text] [Related]
14. Role for ATM in DNA damage-induced phosphorylation of BRCA1.
Gatei M; Scott SP; Filippovitch I; Soronika N; Lavin MF; Weber B; Khanna KK
Cancer Res; 2000 Jun; 60(12):3299-304. PubMed ID: 10866324
[TBL] [Abstract][Full Text] [Related]
15. Histopathological features of breast cancer in carriers of ATM gene variants.
Balleine RL; Murali R; Bilous AM; Farshid G; Waring P; Provan P; Byth K; Thorne H; ; Kirk JA
Histopathology; 2006 Nov; 49(5):523-32. PubMed ID: 17064299
[TBL] [Abstract][Full Text] [Related]
16. Persistence of unrepaired DNA double strand breaks caused by inhibition of ATM does not lead to radio-sensitisation in the absence of NF-κB activation.
Veuger SJ; Durkacz BW
DNA Repair (Amst); 2011 Feb; 10(2):235-44. PubMed ID: 21144805
[TBL] [Abstract][Full Text] [Related]
17. [What do we know about ATM protein expression in breast tissue?].
Angèle S; Tanière P; Hall J
Bull Cancer; 2001 Jul; 88(7):671-5. PubMed ID: 11495820
[TBL] [Abstract][Full Text] [Related]
18. A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer.
Bogdanova N; Cybulski C; Bermisheva M; Datsyuk I; Yamini P; Hillemanns P; Antonenkova NN; Khusnutdinova E; Lubinski J; Dörk T
Breast Cancer Res Treat; 2009 Nov; 118(1):207-11. PubMed ID: 18807267
[TBL] [Abstract][Full Text] [Related]
19. [Adjuvant irradiation in breast cancer patients with ATM gene heterozygous mutations: special focus on clinical efficacy/toxicity].
Chargari C; Kirova YM; Even C; Monnier L; Dendale R; Campana F; Fourquet A
Cancer Radiother; 2009 Jun; 13(3):164-72. PubMed ID: 19162519
[TBL] [Abstract][Full Text] [Related]
20. Effect of ATM heterozygosity on heritable DNA damage in mice following paternal F0 germline irradiation.
Baulch JE; Li MW; Raabe OG
Mutat Res; 2007 Mar; 616(1-2):34-45. PubMed ID: 17161850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]